Ross B. Gordon

659 total citations
20 papers, 547 citations indexed

About

Ross B. Gordon is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ross B. Gordon has authored 20 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Ross B. Gordon's work include Biochemical and Molecular Research (10 papers), Cytomegalovirus and herpesvirus research (8 papers) and HIV/AIDS drug development and treatment (6 papers). Ross B. Gordon is often cited by papers focused on Biochemical and Molecular Research (10 papers), Cytomegalovirus and herpesvirus research (8 papers) and HIV/AIDS drug development and treatment (6 papers). Ross B. Gordon collaborates with scholars based in Australia, United States and France. Ross B. Gordon's co-authors include B. T. Emmerson, Paul A. Dawson, Nicholas P.B. Dudman, Jan P. Kraus, David H. Brown, Barbara I. Brown, D. E. L. Wilcken, R. de Franchis, Mette Gaustadnes and Godfried H.J. Boers and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Nutrition and Gene.

In The Last Decade

Ross B. Gordon

20 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross B. Gordon Australia 12 298 246 117 116 83 20 547
F. Stanley Porter United States 14 115 0.4× 281 1.1× 146 1.2× 64 0.6× 49 0.6× 21 625
Nancy Leslie United States 14 87 0.3× 318 1.3× 402 3.4× 89 0.8× 59 0.7× 24 681
J. B. C. de Klerk Netherlands 21 174 0.6× 569 2.3× 601 5.1× 121 1.0× 66 0.8× 42 1.0k
B. B. Anderson United Kingdom 12 343 1.2× 206 0.8× 140 1.2× 23 0.2× 31 0.4× 23 829
Néji Tebib Tunisia 14 89 0.3× 164 0.7× 89 0.8× 27 0.2× 59 0.7× 66 537
G. Hammersen Germany 12 55 0.2× 218 0.9× 217 1.9× 58 0.5× 48 0.6× 27 565
I. B. Sardharwalla United Kingdom 13 210 0.7× 146 0.6× 195 1.7× 45 0.4× 37 0.4× 37 510
Andrea Bordugo Italy 15 99 0.3× 183 0.7× 164 1.4× 49 0.4× 199 2.4× 35 670
Walla Al‐Hertani Canada 13 48 0.2× 159 0.6× 126 1.1× 47 0.4× 82 1.0× 36 597
C. Schreiber United States 14 272 0.9× 187 0.8× 77 0.7× 8 0.1× 18 0.2× 22 492

Countries citing papers authored by Ross B. Gordon

Since Specialization
Citations

This map shows the geographic impact of Ross B. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross B. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross B. Gordon more than expected).

Fields of papers citing papers by Ross B. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross B. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross B. Gordon. The network helps show where Ross B. Gordon may publish in the future.

Co-authorship network of co-authors of Ross B. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Ross B. Gordon. A scholar is included among the top collaborators of Ross B. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross B. Gordon. Ross B. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dawson, Paul A., Ross B. Gordon, Dianne T. Keough, & B. T. Emmerson. (2005). Normal HPRT coding region in a male with gout due to HPRT deficiency. Molecular Genetics and Metabolism. 85(1). 78–80. 24 indexed citations
2.
Kraus, Jan P., Roseann Mandell, Maria Pia Sperandeo, et al.. (1999). Cystathionine ?-synthase mutations in homocystinuria. Human Mutation. 13(5). 362–375. 220 indexed citations
3.
Kraus, Jan P., Miroslav Janošı́k, Viktor Kožich, et al.. (1999). Cystathionine β-synthase mutations in homocystinuria. Human Mutation. 13(5). 362–362. 8 indexed citations
4.
Gordon, Ross B., Anthony J. Cox, Paul A. Dawson, et al.. (1998). Mutational analysis of the cystathionine β-synthase gene: A splicing mutation, two missense mutations and an insertion in patients with homocystinuria. Human Mutation. 11(4). 332–332. 5 indexed citations
5.
Dawson, Paul A., Anthony J. Cox, B. T. Emmerson, et al.. (1997). Characterisation of Five Missense Mutations in the Cystathionine Beta-Synthase Gene from Three Patients with B(6)-Nonresponsive Homocystinuria. European Journal of Human Genetics. 5(1). 15–21. 22 indexed citations
6.
Dudman, Nicholas P.B., et al.. (1996). Human Homocysteine Catabolism: Three Major Pathways and Their Relevance to Development of Arterial Occlusive Disease. Journal of Nutrition. 126(4 Suppl). 1295S–1300S. 68 indexed citations
7.
Sahota, Amrik, Ju Chen, Nada H. Khattar, et al.. (1995). Molecular Characterization of a Novel Mutation in APRT Heterozygotes. Advances in experimental medicine and biology. 370. 675–678. 2 indexed citations
8.
Devlin, Cecilia, Mark R. Bowles, Ross B. Gordon, & Susan M. Pond. (1995). Production of a Paraquat-Specific Murine Single Chain Fv Fragment1. The Journal of Biochemistry. 118(3). 480–487. 7 indexed citations
9.
Gordon, Ross B., et al.. (1995). A simple method for synthesis of B‐cell clonospecific probes. British Journal of Haematology. 91(3). 575–577. 1 indexed citations
10.
Dawson, Paul A., Duncan A.E. Cochran, B. T. Emmerson, & Ross B. Gordon. (1993). Inhibition of Plasmodium falciparum hypoxanthine-guanine phosphoribosyltransferase mRNA by antisense oligodeoxynucleotide sequence. Molecular and Biochemical Parasitology. 60(1). 153–156. 22 indexed citations
11.
Pryor, Gordon T., et al.. (1991). The hearing loss associated with exposure to toluene is not caused by a metabolite. Brain Research Bulletin. 27(1). 109–113. 27 indexed citations
12.
Gordon, Ross B., et al.. (1991). The molecular characterisation of hprtchermside and HPRTcoorparoo: two Lesch-Nyhan patients with reduced amounts of mRNA. Gene. 108(2). 299–304. 10 indexed citations
13.
Gordon, Ross B., et al.. (1990). Expression of active human hypoxanthine-guanine phosphoribosyltransferase in Escherichia coli and characterisation of the recombinant enzyme. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1087(2). 205–211. 18 indexed citations
15.
Emmerson, B. T. & Ross B. Gordon. (1986). HGPRT Deficiency with Normal Erythrocyte PRPP and APRT Activity. Advances in experimental medicine and biology. 195 Pt A. 163–165. 1 indexed citations
16.
Gordon, Ross B., et al.. (1979). Regulation of purine de novo synthesis in cultured human fibroblasts: The role of. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 562(1). 162–176. 26 indexed citations
17.
Johnson, Lambro A., Ross B. Gordon, & B. T. Emmerson. (1979). Inactivation of hypoxanthine guanine phosphoribosyltransferase by guanosine dialdehyde: An active site directed inhibitor. Biochemical Medicine. 22(1). 33–42. 4 indexed citations
18.
19.
Brown, David H., Ross B. Gordon, & Barbara I. Brown. (1973). STUDIES ON THE STRUCTURE AND MECHANISM OF ACTION OF THE GLYCOGEN DEBRANCHING ENZYMES OF MUSCLE AND LIVER*. Annals of the New York Academy of Sciences. 210(1). 238–253. 11 indexed citations
20.
Gordon, Ross B., David H. Brown, & Barbara I. Brown. (1972). Preparation and properties of the glycogen-debranching enzyme from rabbit liver. Biochimica et Biophysica Acta (BBA) - Enzymology. 289(1). 97–107. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026